Clinical Trial Update: Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating efficacy and safety of Subetta in combination treatment for Type I diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Subetta

Snippet

Sponsor: Materia Medica Holding | Conditions: Type I Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-03-04